Our efforts to monitor beta cells after transplant and identify signs of early demise in both native and transplanted cells will make it possible to
stop cell injury, significantly advancing prevention efforts and strengthening transplant techniques.
Not exact matches
One is using
cells derived from human embryonic stem
cells to treat spinal cord
injury (although funding problems have
stopped the trial enrolling new patients) and another is testing a treatment for age - related macular degeneration.
Inflammation is essential to
stopping the spread of infection, and for allowing the transport of inflammatory
cells to the site of the
injury.
As scientists continue to explore the
injury and recovery process of spinal cord
injuries, experimental treatments may be available to
stop cell death, control swelling and nerve regeneration.